Erchonia Corporation Wins Default Judgment in Green Laser Patent Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Erchonia Corporation LLC v. The Partnerships and Unincorporated Associations Identified on Schedule A |
| Case Number | 1:25-cv-10560 |
| Court | U.S. District Court for the Northern District of Illinois |
| Duration | 140 days ~4 months 20 days |
| Outcome | Plaintiff Win — Permanent Injunction |
| Patents at Issue | |
| Accused Products | LuxMaster Slim, Maxlipo Master, and Glaser product lines |
Case Overview
The Parties
⚖️ Plaintiff
A recognized innovator in low-level laser therapy, holding a substantial patent portfolio in photobiomodulation and non-invasive body contouring technologies.
🛡️ Defendant
The standard pleading mechanism used in multi-defendant e-commerce infringement cases, consolidating numerous anonymous or pseudonymous online sellers into a single action.
Patents at Issue
This landmark case involved two U.S. patents covering green laser therapy device technology. Both patents represent Erchonia’s core intellectual property in non-invasive laser-based aesthetic and therapeutic treatment platforms.
- • US7947067B2 — directed to laser therapy device technology in the green wavelength spectrum
- • US9149650B2 — covering related laser system configurations used in body contouring applications
Developing new laser therapy products?
Check if your green laser design might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The court granted Plaintiff’s Motion for Entry of Default and Default Judgment in full, entering a permanent injunction against all defaulting defendants. No monetary damages figure was disclosed in the available case record; the judgment focused primarily on injunctive and platform-level relief.
Key Legal Issues
The ruling underscores the viability of Schedule A “John Doe” complaints for pursuing anonymous e-commerce infringers and the successful extension of platform-level injunctions to patent enforcement contexts, creating meaningful operational leverage against cross-border infringers. The injunction notably requires platforms including AliExpress, Alibaba, DHGate, Made-In-China, and Aimylin.com to disable associated accounts and remove advertisements for the infringing products.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in green laser therapy technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in medical device patents
- Understand claim construction patterns for green lasers
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Green Laser Therapy Devices
2 Patents Enforced
Covering core green laser tech
Design-Around Options
Available for most claims
✅ Key Takeaways
Schedule A default judgments in the N.D. Illinois remain an efficient mechanism for multi-defendant e-commerce patent enforcement.
Search related case law →Platform-level injunctions against AliExpress, Alibaba, and DHGate are being granted in patent — not only trademark — contexts.
Explore precedents →Conduct FTO analysis against US7947067B2 and US9149650B2 before launching any green laser body contouring product in the U.S. market.
Start FTO analysis for my product →Third-party marketplace distribution does not insulate manufacturers from injunctive reach; plan your market entry accordingly.
Try AI patent drafting →Frequently Asked Questions
The case involved U.S. Patent Nos. US7947067B2 (App. No. 11/409408) and US9149650B2 (App. No. 14/336401), both covering green laser therapy device technology.
Defendants failed to appear or respond to the complaint. Under FRCP Rule 55, the court accepted Erchonia’s well-pled infringement allegations as admitted and entered judgment accordingly.
It affirms that Schedule A enforcement paired with marketplace platform injunctions is viable in patent cases, likely encouraging similar actions by other medical device patent holders against e-commerce infringers.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- PACER Case Lookup — 1:25-cv-10560
- USPTO Patent Center — US7947067B2
- USPTO Patent Center — US9149650B2
- U.S. District Court for the Northern District of Illinois Information
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Green Laser Product?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis.
Run FTO for My Product